HomeDNTH • NASDAQ
add
Dianthus Therapeutics Inc
Previous close
$20.27
Day range
$20.37 - $22.39
Year range
$6.69 - $33.77
Market cap
661.20M USD
Avg Volume
276.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.17M | 135.06% |
Operating expense | 32.07M | 92.24% |
Net income | -25.17M | -70.52% |
Net profit margin | -1.16K | 27.46% |
Earnings per share | — | — |
EBITDA | -29.88M | -89.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 281.12M | 48.06% |
Total assets | 354.25M | 84.06% |
Total liabilities | 16.35M | 16.11% |
Total equity | 337.90M | — |
Shares outstanding | 29.60M | — |
Price to book | 1.76 | — |
Return on assets | -20.67% | — |
Return on capital | -21.45% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -25.17M | -70.52% |
Cash from operations | -21.27M | -112.84% |
Cash from investing | -259.36M | -2,154.36% |
Cash from financing | 296.00K | -99.79% |
Net change in cash | -280.34M | -339.72% |
Free cash flow | -10.22M | -567.97% |
About
Founded
2019
Website
Employees
53
